Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 8-K Quarterly results
08/16/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "CORRECTED CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF HELIUS MEDICAL TECHNOLOGIES, INC. Helius Medical Technologies, Inc., a corporation organized and existing under the laws of the State of Delaware , certifies that: 1.            The Certificate of Amendment to the Certificate of Incorporation that was filed with the Delaware Secretary of State on August 15, 2023 requires correction as permitted by Section 103 of the Delaware General Corporation Law. 2.            The defect in such Certificate of Amendment to the Certificate of Incorporation is as follows: The Certificate of Amendment to the Certificate of Incorporation shall...",
"Lisa M. Wilson, In-Site Communications, Inc."
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
05/26/2023 4 STRAW EDWARD M (Director) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.
Txns: Granted 83,054 shares @ $0
Granted 284,865 options to buy @ $0.1561, valued at $44.5k
05/26/2023 4 Perkins Sherrie L (Director) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.
Txns: Granted 83,054 shares @ $0
Granted 284,865 options to buy @ $0.1561, valued at $44.5k
05/26/2023 4 Walter Blane (Director) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.
Txns: Granted 83,054 shares @ $0
Granted 284,865 options to buy @ $0.1561, valued at $44.5k
05/25/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
04/21/2023 ARS Form ARS - Annual Report to Security Holders:
04/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/24/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications t...
03/24/2023 8-A12G Form 8-A12G - Registration of securities [Section 12(g)]:
03/09/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 8-K Quarterly results
02/08/2023 SC 13G Hudson Bay Capital Management LP reports a 9.7% stake in Helius Medical Technologies, Inc.
02/08/2023 SC 13G/A INTRACOASTAL CAPITAL, LLC reports a 5.1% stake in Helius Medical Technologies, Inc.
01/23/2023 8-K Investor presentation
01/19/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/25/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
11/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/14/2022 8-K Quarterly results
09/30/2022 8-K Quarterly results
09/23/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
09/14/2022 4 Favit-Van Pelt Antonella R. (Chief Medical Officer) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.
Txns: Granted 10,000 options to buy @ $0.54, valued at $5.4k
09/14/2022 4 MATHIESEN JEFFREY S (CFO and Treasurer) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.
Txns: Granted 18,000 options to buy @ $0.54, valued at $9.7k
09/14/2022 4 ANDREEFF DANE (President and CEO) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.
Txns: Bought 4,752 shares @ $0.5444, valued at $2.6k
Bought 1,014 shares @ $0.5444, valued at $552
Bought 2,838 shares @ $0.5444, valued at $1.5k
Bought 264 shares @ $0.5444, valued at $143.7
Bought 150,000 shares @ $0.5347, valued at $80.2k
Granted 86,000 options to buy @ $0.54, valued at $46.4k
08/26/2022 4 ANDREEFF DANE (President and CEO) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.
Txns: Bought 13,503 shares @ $0.6499, valued at $8.8k
Bought 2,881 shares @ $0.6499, valued at $1.9k
Bought 8,064 shares @ $0.6499, valued at $5.2k
Bought 752 shares @ $0.6499, valued at $488.7
Bought 40,082 shares @ $0.63, valued at $25.3k
Bought 8,550 shares @ $0.63, valued at $5.4k
Bought 23,937 shares @ $0.63, valued at $15.1k
Bought 2,231 shares @ $0.63, valued at $1.4k
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/15/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy